Previous Page  7 / 42 Next Page
Information
Show Menu
Previous Page 7 / 42 Next Page
Page Background

Page 66

Notes:

conferenceseries

.com

Volume 7, Issue 6 (Suppl)

J Bacteriol Parasito

ISSN: 2155-9597 JBP, an open access journal

Microbiology 2016

November 28-29, 2016

November 28-29, 2016 Valencia, Spain

7

th

World Congress on

Microbiology

Daniel Oliver Connor, J Bacteriol Parasitol 2016, 7:6 (Suppl)

http://dx.doi.org/10.4172/2155-9597.C1.026

Identification of immunogenic proteins of human pathogenic bacteria utilizing phage display

Daniel Oliver Connor

Fraunhofer Institute for Cell Therapy and Immunology-IZI, Germany

R

ecent evolutionary development of antibiotic resistances of many human pathogens leads to an inevitable necessity to discover

new ways in diagnostics and treatment of those pathogenic bacteria. Unfortunately, knowledge of suitable antigens and promising

protein candidates is not provided for many pathogens. Therefore, the aim of this study was to identify novel immunogenic proteins

of three different human pathogenic bacteria:

Borrelia burgdorferi

,

Neisseria gonorrhoeae

and

Neisseria meningitidis

. Genomic

phage display libraries of all three pathogens were constructed with 106-107 individual clones and screened for the identification

of immunogenic proteins. Subsequently, corresponding full length proteins were expressed and their immunogenic character

verified by ELISA. 21 potentially immunogenic proteins were identified for

N. gonorrhoeae

wherefrom six proteins were described

as immunogenic for the first time. The determined immunogenic proteins of

and

N. meningitidis

had been mostly

described in literature but could be verified in this work. Additionally, these results showed that the identification of immunogenic

proteins utilizing phage display is feasible for human pathogenic bacteria and a fast and straightforward approach. The identified

proteins will be further examined for linear epitopes to identify the immunodominant regions. Furthermore, ongoing studies

include the development of recombinant antibodies against the identified proteins. These antibodies will then be used for further

characterization of the identified immunogenic proteins and to investigate their potential as suitable candidates including diagnostics.

Biography

Daniel Oliver Connor has recently submitted his PhD thesis at the University of Potsdam including two first author peer reviewed publications. He has completed

his BSc at the Hochschule Furtwangen University and MSc at the Westfälische Wilhelms-Universität Münster. He has contributed his knowledge and scientific

experience at Merckle Biotech, NMI Tübingen and the Fraunhofer IZI-BB (formerly IBMT) in Potsdam.

daniel.connor@izi-bb.fraunhofer.de